STOCK TITAN
  1. Home
  2. News
  3. DH

Definitive Healthcare Corp - DH STOCK NEWS

Welcome to our dedicated news page for Definitive Healthcare (Ticker: DH), a resource for investors and traders seeking the latest updates and insights on Definitive Healthcare.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Definitive Healthcare's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Definitive Healthcare's position in the market.

News
Definitive Healthcare Announces Timing of Its First Quarter 2024 Financial Results Conference Call and Webcast
Rhea-AI Summary
Definitive Healthcare Corp. (DH) will report its Q1 2024 financial results on May 7, 2024, after market close. The conference call and webcast to discuss the results will be held at 5:00 PM (ET) / 2:00 PM (PT). Investors can access the live webcast on the company's Investor Relations website. A replay will be available until June 6, 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.28%
Tags
earnings
-
News
Definitive Healthcare introduces Carevoyance sales enablement solution for medtech industry
Rhea-AI Summary
Definitive Healthcare launches Carevoyance sales enablement solution for medtech industry, offering streamlined workflows and data-driven insights to accelerate sales cycles and improve targeting.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.1%
Tags
none
-
News
VML and Definitive Healthcare announce partnership to transform key opinion leader management
Rhea-AI Summary
Definitive Healthcare (Nasdaq: DH) and VML Health form a groundbreaking partnership to streamline engagement between pharmaceutical companies and key opinion leaders (KOLs), enhancing clinical collaborations globally.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.79%
Tags
partnership
News
Definitive Healthcare earns 2024 Middle Market Leader Award from Boston Business Journal
Rhea-AI Summary
Definitive Healthcare (DH) has been named one of the Boston Business Journal’s Middle Market Leaders for 2024, showcasing significant revenue growth from 2020 to 2022. The company's total revenue increased from $118.3 million to $222.7 million during this period, marking a 34% year-over-year growth. Definitive Healthcare's recognition highlights its commitment to providing valuable healthcare commercial intelligence and its strong financial performance.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.16%
Tags
none
-
News
Definitive Healthcare Reports Financial Results for Fourth Quarter and Full Fiscal Year 2023
Rhea-AI Summary
Definitive Healthcare Corp. reported a 9% increase in fourth-quarter revenue to $65.9 million and a 13% increase in full-year revenue to $251.4 million in 2023. The company also announced customer wins and financial guidance for 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.48%
Tags
earnings
-
News
Definitive Healthcare Announces Timing of Its Fourth Quarter and Full Year 2023 Financial Results Conference Call and Webcast
Rhea-AI Summary
Definitive Healthcare Corp. will report financial results for Q4 and full year 2023 on February 28, 2024. The company will host a conference call to discuss the results. Investors can access the live webcast or dial-in for the call.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.76%
Tags
earnings
News
Definitive Healthcare Announces CEO Transition
Rhea-AI Summary
Definitive Healthcare (Nasdaq: DH) announced the appointment of Jason Krantz as interim CEO, following the departure of Robert Musslewhite. The company reaffirmed its Q4 2023 financial guidance and issued preliminary guidance for 2024, expecting revenue to grow 5-7% and adjusted EBITDA margin to increase by approximately 200 basis points. The leadership transition aims to position the organization for further growth, with Mr. Krantz expressing confidence in the company's potential for long-term value creation.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.58%
Tags
none
-
News
Established Executive and Milwaukee Business Leader Jim Emling Joins VBA as Executive Chair of the Board of Directors
Rhea-AI Summary
Datassential's former CEO, Jim Emling, has been appointed Executive Chair of the Board of Directors at VBA, a company heavily investing in sales and product development after closing a growth equity transaction led by Spectrum Equity and Arthur Ventures. VBA serves the entire payer landscape, including third party administrators (TPAs) and health plans, with its next-gen Core Administrative Processing System, user engagement platforms, customer support tools, population health reporting solution, and robust data connections.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
management
-
News
Definitive Healthcare Corp. reports inducement grants under Nasdaq Listing Rule 5635(c)(4)
Rhea-AI Summary
Definitive Healthcare has announced the hiring of Carrie Lazorchak as its new Chief Revenue Officer. As part of her employment agreement, Lazorchak has been granted 385,695 time-based restricted stock units (RSUs) effective November 1, 2023. The RSUs will vest over a 4-year period, with 25% vesting on the 1-year anniversary of the grant date and the remainder vesting in quarterly installments over the subsequent 3 years.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
News
Definitive Healthcare Reports Financial Results for Third Quarter Fiscal Year 2023
Rhea-AI Summary
Definitive Healthcare Corp. reported a 14% year-over-year increase in revenue for the third quarter, reaching $65.3 million. The net loss was ($248.7) million, compared to ($6.9) million in the same period last year. Adjusted Net Income and Adjusted EBITDA also showed improvement, reaching $14.6 million and $21.7 million, respectively. The company's cash flow from operations was $9.5 million in the quarter, while unlevered free cash flow was $17.7 million.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
19.97%
Tags
earnings
Stock DH logo
Definitive Healthcare Corp

Nasdaq:DH

DH Rankings

#2559 Ranked by Market Cap
#4960 Ranked by Stock Gains
N/A Ranked by Dividends

DH Stock Data

865.75M
53.23M
2.61%
99.67%
6.32%
Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
Professional, Scientific, and Technical Services
Link
United States
Framingham

About DH

definitive healthcare is the leading provider of data and intelligence on hospitals, physicians and other healthcare providers. their product suite provides the most comprehensive and highest quality data available anywhere on over 8,100 hospitals and idns, 7,300 ambulatory surgery centers, 11,000 imaging centers, 38,000 long-term care facilities, 1,200 acos and hies, 197,000 physician groups, 1.3 million physicians, and 750 canadian hospitals. the company’s data provides clients with the analytics and insight needed to effectively segment and research the healthcare provider market. definitive healthcare is backed by spectrum equity. for more information or to trial the service, visit www.definitivehc.com.